Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

STAA - STAAR SURGICAL CO


IEX Last Trade
24.39
0.050   0.205%

Share volume: 5,727
Last Updated: Fri 27 Dec 2024 08:30:05 PM CET

PREVIOUS CLOSE
CHG
CHG%

$24.34
0.05
0.21%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
1.78%
1 Month
-12.70%
3 Months
-33.92%
6 Months
-47.40%
1 Year
-22.35%
2 Year
-48.73%
Key data
Stock price
$24.39
P/E Ratio 
97.97
DAY RANGE
$24.00 - $24.61
EPS 
$0.34
52 WEEK RANGE
$24.76 - $52.68
52 WEEK CHANGE
-$21.18
MARKET CAP 
1.628 B
YIELD 
N/A
SHARES OUTSTANDING 
49.188 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
BETA 
1.61
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$645,992
AVERAGE 30 VOLUME 
$587,091
Company detail
CEO: Caren L. Mason
Region: US
Website: staar.com
Employees: 960
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

STAAR Surgical Company designs, develops, manufactures, markets, and sells implantable lenses for the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems.

Recent news